看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。+ h* p5 Q X. c# ^
- Q- ]2 L) u) ]: @' [7 {, r$ m% O
1 r G k$ x! }- _0 W; _
Currently available feasibility data for possible combination strategies. ! ]2 {0 K9 L( l# t
————————————————————————————————2 h8 o' u# E; \5 Y& w* q$ U' J
Combination Feasibility according to preliminary data
; v% u8 ^& T! ]" D——————————————————————————————————
: }- d- X* F# ABevacizumab + sorafenib Yes, reduced dose $ ^- N" i- N8 f* {* N) |) d
Bevacizumab + sunitinib† No
7 V" E/ D, H( nBevacizumab + temsirolimus Yes 4 r" R7 _: h2 y9 N" c* |
Bevacizumab + everolimus Yes
1 O- ?7 w2 C6 C' |7 a) g& |/ f2 dSorafenib + sunitinib ?
' j& A4 {; V- p4 g" BSorafenib + temsirolimus Yes, reduced dose . z, k# ]" m% c+ ~6 V
Sorafenib + everolimus Yes, reduced dose
* W2 V4 J. O) iSunitinib + temsirolimus† No
; @9 g! J9 C z8 @- }1 t4 bSunitinib + everolimus ?
W* q" U. H. t5 }3 {Temsirolimus + everolimus ? 4 h$ u6 i1 W8 h3 H& ] }
————————————————————
8 \7 g Z- Q9 t†Led to US FDA warning.
0 I9 Q$ C3 J/ I3 A?: As yet unattempted combination.
7 L ?9 T3 r. H1 S- _( ^# F |